<DOC>
	<DOCNO>NCT00888199</DOCNO>
	<brief_summary>The purpose clinical trial determine experimental Tensegrity prosthetic foot offer reduction amount oxygen use walking , stability improve current prosthetic foot , whether experimental device actually increase activity amputee .</brief_summary>
	<brief_title>Clinical Trial Tensegrity Prosthetics K3 Promoter Foot Prosthesis</brief_title>
	<detailed_description>Tensegrity Prosthetics ' objective test whether K3 Promoter prosthetic foot affect walk efficiency stability trans-tibial unilateral amputee compare current prosthesis . The primary objective determine experimental foot change Cost Transport ( ml O2/kg/meter ) Stride Time Variability compare amputee 's current prosthesis . Cost Transport indicator metabolic efficiency Stride Time Variability indicate likely person fall . Oxygen consumption stride time collect treadmill Gait Motion Lab University Colorado Boulder .</detailed_description>
	<criteria>1 . K2 K3 classification base current prosthetic device . 2 . Males females â‰¥ 18 year age 3 . Willing able sign inform consent 4 . Able read , write , speak English 5 . Documented unilateral transtibial amputation 6 . Actively utilizing definitive prosthesis least 12 month 7 . Utilizing current prosthetic foot least 3 month 8 . Cognitively functional , opinion prosthetist ' 9 . Able maintain good gait exist limb approximately 45 minute 10. healthy residual limb good condition 11. socket good , troublefree fit residual limb 1 . Significant ulcer infection associate compromised circulation lower limb 2 . Intermittent Claudication Critical Leg Ischemia nonamputated leg 3 . K0 , K1or K4 Classification 4 . Irreducible , pronounced knee hip flexion contractures 5 . Bilateral amputation 6 . Use walker ambulation 7 . Severe arthritis would limit ability stand without pain discomfort subject 's ability ambulate limit symptom prothesis ( e.g. , shortness breath , fatigue , angina , arthritis , etc. ) . If , opinion investigator , subject improve ability ambulate K3 Promoter extent walk would limited symptom prothesis , subject enrol 8 . Any clinically significant medical psychiatric condition opinion Investigator could impact subject 's ability successfully complete trial 9 . Advanced neurologic disorder 10 . Severe congestive heart failure , angina pectoris , obstructive pulmonary disease 11 . Use medication cause impaired balance judgment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>amputation</keyword>
	<keyword>amputee</keyword>
	<keyword>prosthetic</keyword>
	<keyword>foot</keyword>
	<keyword>prosthesis</keyword>
	<keyword>Tensegrity</keyword>
	<keyword>Prosthetics</keyword>
	<keyword>K3 Promoter</keyword>
</DOC>